LK
Llew Keltner
Director

Llew Keltner insider trades: Raptor Pharmaceutical (RPTP) stock buys and sales

Director, Raptor Pharmaceutical Last trade Jul 1, 2015 25 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2012
3
Companies
last trade 2015

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Llew reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 1, 2015RPTP↓ Sell$803K
Jul 7, 2014RPTP↓ Sell$112K
May 30, 2014RPTP↑ Buy$837
Mar 7, 2014RPTP↓ Sell$157K
Jan 7, 2014RPTP↓ Sell$133K
Nov 7, 2013RPTP↓ Sell$141K
Nov 26, 2012RPTP↓ Sell$5K
Sep 17, 2012RPTP↓ Sell$5K
Aug 1, 2012RPTP↓ Sell$5K
May 15, 2012RPTP↓ Sell$5K
Mar 15, 2012RPTP↓ Sell$7K
Feb 15, 2012RPTP↓ Sell$7K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Llew Keltner's insider trades

Llew Keltner is a director at Raptor Pharmaceutical (RPTP). Since Feb 15, 2012, Llew has reported 1 open-market purchase worth $837 and 11 sales worth $1.4M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (12 filings), option exercises (11 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RPTP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.